Anti-Epstein-Barr virus (EBV) activity of β-L-5-iododioxolane uracil is dependent on EBV thymidine kinase

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 12, 2000, Pages 3278-3284

  Kira, T ^a   Grill, S P ^a   Dutschman, G E ^a   Lin, J S ^a   Qu, F ^a   Choi, Y ^a   Chu, C K ^a   Cheng, Y C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BETA LEVO 5 IODODIOXOLANE URACIL; CLEVUDINE; THYMIDINE KINASE; THYMIDINE KINASE INHIBITOR; UNCLASSIFIED DRUG; URACIL DERIVATIVE; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; VIRUS REPLICATION;

ANTIVIRAL AGENTS; DIOXOLANES; DRUG INTERACTIONS; ENZYME INHIBITORS; HERPESVIRUS 4, HUMAN; HUMANS; SUBSTRATE SPECIFICITY; THYMIDINE; THYMIDINE KINASE; TUMOR CELLS, CULTURED; URACIL; VIRUS REPLICATION;

EID: 0034424308     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.12.3278-3284.2000     Document Type: Article

References (59)

1. Detection and characterization of Epstein-Barr virus in clinical specimens
2. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma
3. Deoxycytidine deaminase-resistant stereoisomer is the active form of (±)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication
4. - cells by herpes simplex virus type I and type II. Purification and characterization
5. Antiviral action and cellular toxicity of four thymidine analogues: 5-Ethyl-, 5-vinyl-, 5-propyl-, and 5-allyl-2′-deoxyuridine
6. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy) methyl]-guanine against herpesvirus in vitro and its mode of action against herpes simplex virus type I
7. Use of 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus
8. The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH-189) both inhibit human immunodeficiency virus replication in vitro
9. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication
10. Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant
11. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy
12. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues
13. High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease
14. Metabolism of 2′,3′-dideoxy-2′,3′-didehydro-β-L(-) -5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus β-D(+) nucleoside analogs in vitro
15. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis
16. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion
17. Efficacy of desciclovir in the treatment of Epstein-Barr virus infection in oral hairy leukoplakia
18. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: Risk factors, treatment and outcome
19. Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration
20. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase
21. Epstein-Barr virus in Hodgkin's disease
22. Use of antigen expressed in bacteria for detection of EBV-specific thymidine kinase antibodies in sera from the patients with nasopharyngeal carcinoma
23. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma
24. Unique inhibitory effect of L-(2′-deoxy-2′-fluoro-β-L-arabinofuranosyl)-5-methyluracil 5′-triphosphate on Epstein-Barr virus and human DNA polymerases
25. Human deoxythymidine kinase. I. Purification and general properties of the cytoplasmic and mitochondrial isozyme derived from blast cells of acute myelocytic leukemia
26. Cellular transformation by the herpesviruses and antiviral drugs
27. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine on Epstein-Barr virus replication
28. Structure activity relationship of L-dioxolane uracil analogues against EBV replication
29. Synthesis and biological evaluation of 2′,3′-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV)
30. Design and synthesis of 2′,3′-dideoxy-2′,3′-didehydro-β-L-5-cytidine (β-L-d4C), and 2′,3′-dideoxy-2′,3′-didehydro-β-L-5- fluorocytidine (β-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro
31. Identification of an Epstein-Barr virus-encoded thymidine kinase
32. Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins
33. Cloning and expression of a cDNA encoding the Epstein-Barr virus thymidine kinase gene
34. Unique metabolism of a novel antiviral L-nucleoside analog, 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil: A substrate for both thymidine kinase and deoxycytidine kinase
35. Epstein-Barr virus and human T-cell lymphomas
36. The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl) cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice
37. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus
38. Epstein-Barr virus and gastric carcinoma
39. Inhibition of hepatitis B virus by a novel L-nucleoside, 2′-fluoro-5-methyl-β-L-arabinofuranosyl uracil
40. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferation and Hodgkin's disease: Two new developments in the EBV field
41. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation
42. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxy-methyl)-1,3-oxathiolan-5-yl]cytosine
43. Epstein-Barr virus-associated B cell lymphoproliferative disorders following bone marrow transplantation
44. Epstein-Barr virus induces a unique pyrimidine deoxynucleoside kinase activity in superinfected and virus-producer B cell line
45. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell line (GT38 and GT39) derived from gastric tissues
46. Substrate specificity of Epstein-Barr virus thymidine kinase
47. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia
48. In situ demonstration of Epstein-Barr viral genomes in viral associated B cell lymphoproliferations
49. Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification
50. Characterization of sublines of Epstein-Barr virus producing HR-1 cells and its implication in virus propagation in culture
51. Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil
52. Introduction: Epstein-Barr virus and non-B cell tumours
53. Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: Novel antiviral mechanism of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
54. A major DNA binding protein encoded by BALF2 open reading frame of Epstein-Barr virus (EBV) forms a complex with other EBV DNA-binding proteins: DNAase, EA-D, and DNA polymerase
55. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines
56. Anti-hepatitis B virus activity and metabolism of 2′,3′-dideoxy-2′,3′-didehydro-β-L(-)-5- fluorocytidine
57. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx
58. Epstein-Barr virus lymphoproliferation after bone marrow transplantation